Works matching IS 13570560 AND DT 2022 AND VI 39 AND IP 4
Results: 12
Balstilimab and other immunotherapy for recurrent and metastatic cervical cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The analysis of N6-methyladenosine regulators impacting the immune infiltration in clear cell renal cell carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Combination of dasatinib and okadaic acid induces apoptosis and cell cycle arrest by targeting protein phosphatase PP2A in chronic myeloid leukemia cells.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
ErbB2 promotes breast cancer metastatic potential via HSF1/LDHA axis-mediated glycolysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The role of the WNT signaling pathway in the maxillary sinus squamous cell carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Interferon regulatory factor-1 regulates cisplatin-induced apoptosis and autophagy in A549 lung cancer cells.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancer.
- Published in:
- Medical Oncology, 2022, v. 39, n. 4, p. 1, doi. 10.1007/s12032-021-01637-0
- By:
- Publication type:
- Article
CDK9 inhibitors in multiple myeloma: a review of progress and perspectives.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A 12-chemokine gene signature is associated with the enhanced immunogram scores and is relevant for precision immunotherapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A linkage between effectual genes in progression of CRC through canonical and non-canonical TGF-β signaling pathways.
- Published in:
- 2022
- By:
- Publication type:
- journal article
RNF144A exerts tumor suppressor function in breast cancer through targeting YY1 for proteasomal degradation to downregulate GMFG expression.
- Published in:
- Medical Oncology, 2022, v. 39, n. 4, p. 1, doi. 10.1007/s12032-021-01631-6
- By:
- Publication type:
- Article